Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Examining the Integration of Hospitals, Public Health, and Social Services to Target the Social Determinants of Health Using Patient-Centered and Comparative Effectiveness Research Methods
Research Methods Core
Ras Induced Senescence and Tumor Suppression
Developmental signals and global transcriptional control
US Valuation of the Euroqol EQ-5 Health States
Recently added grants:
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure
Adaptive intervention strategies to optimize PrEP clinical evaluation and uptake in stimulant-using men
Health and Economic Outcomes of Treatment with Extended-Release Naltrexone Among Pre-Release Prisoners with Opioid Use Disorder
Opioid Overdoses among Medicaid Beneficiaries: Predictors, Outcomes, and State Policy Effects
TMS in Primary Progressive Aphasia: Modulation of Brain Networks and Language
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07153-17-0-1
Application #
7574913
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Johns Hopkins University
$389,122
NIH 2007
N01 HL
Pediatric Hydroxyuera Phase III Clinical Trial
Casella, James F. /
$523,182
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant